Dinutuximab beta for treating neuroblastoma: an evidence review group and decision support unit perspective of a NICE single technology appraisal

Pennington, B. orcid.org/0000-0002-1002-022X, Ren, S. orcid.org/0000-0003-3568-7124, Barton, S. et al. (2 more authors) (2018) Dinutuximab beta for treating neuroblastoma: an evidence review group and decision support unit perspective of a NICE single technology appraisal. PharmacoEconomics. ISSN 1170-7690

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2018 Springer Nature Switzerland AG. This is an author produced version of a paper subsequently published in PharmacoEconomics. Uploaded in accordance with the publisher's self-archiving policy.
Dates:
  • Published (online): 22 November 2018
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > Sheffield Centre for Health and Related Research
Depositing User: Symplectic Sheffield
Date Deposited: 04 Jan 2019 13:31
Last Modified: 04 Jan 2019 13:31
Published Version: https://doi.org/10.1007/s40273-018-0744-0
Status: Published online
Publisher: Springer Verlag
Refereed: Yes
Identification Number: https://doi.org/10.1007/s40273-018-0744-0

Downloads

Accepted Version


Embargoed until: 22 November 2019

Filename: 2018 10 18 dtx beta paper v 3 0 clean.pdf

Request a copy

Supplemental Material


Embargoed until: 22 November 2019

Filename: figure1.jpg

Request a copy

Supplemental Material


Embargoed until: 22 November 2019

Filename: figure2.jpg

Request a copy

Supplemental Material


Embargoed until: 22 November 2019

Filename: figure3.jpg

Request a copy

Share / Export

Statistics